David Anderson

Company: Clinical Ink

Job title: PhD, Director, Science & Innovation

Seminars:

TrialReady: A Real-Time Continuous Symptom Monitoring Platform to Improve GLP-1 Study Adherence, Reduce Trial Risk Metrics, and Track Multimodal Changes in Physiological Endpoints 11:10 am

Review multidomain patterns of GLP-1 associated symptoms Introduce TrialReady as the only platform to monitor GLP-1 associated symptoms in real time Discuss behavioral characterization tools to improve adherence and reduce dropoutRead more

day: Day Two